Pulmonary Hypertension Treatment: An In-Depth Look at What Riociguat Is Used For
Pulmonary hypertension (PH) is a progressive and potentially life-threatening condition characterized by persistently elevated pressure…
News
The Role of Pharmaceutical Wholesalers in 2026: From Channel to Strategic Partner Aligning with Drugmakers’ 6 Priorities
As innovation in drug research and development continues to accelerate, the pharmaceutical industry is entering…
The Different Forms of Navelbine—From Classic Chemotherapy to a Flexible Multi-Formulation Therapy
In the era of precision oncology, an effective treatment strategy requires more than just a…
What Are Hengmu Tenofovir Tablets Used For? Indications, Mechanism, and Safety Advantages in Chronic Hepatitis B
In China, chronic hepatitis B remains a major public health challenge, affecting tens of millions…
2026 Pharma Trends 丨 Which 11 Drugs Will Define the Future of Pharma?
As global demographic shifts, evolving disease landscapes, and rising expectations for treatment experience continue to…
A Safer Approach to HDAC Inhibition: Chidamide (Epidaza) for Lymphoma and Breast Cancer
In the field of oncology, relapsed or refractory peripheral T-cell lymphoma (PTCL) and endocrine therapy…
Redefining Late-Line Therapy in Advanced GIST: What is The Mechanism of Action of Ripretinib?
The treatment of advanced gastrointestinal stromal tumors (GIST) is a long and arduous race against…
Biktarvy: How Does a Three-Drug-in-One Regimen Define the Gold Standard in HIV Treatment?
In the field of HIV antiviral therapy, “simplification” and “potency” have long been the two…
TPIAO Approved for a New Indication: Clinical Progress of Recombinant Human Thrombopoietin in the Treatment of Thrombocytopenia
(China, December 23, 2025) — Sunshine Guojian Pharmaceutical, a leading biopharmaceutical company in China, today…
Good News for Patients with Blood Cancers! World’s Third BCL-2 Inhibitor——Sonrotoclax Approved in China
On January 6, 2026, BeiGene (Suzhou) Biotech Co., Ltd. (BeiGene) ‘s independently developed innovative drug…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights